The Indiana Clinical and Translational Sciences Institute, which includes the University of Notre Dame as a member, has received a nearly $30 million grant from the National Institutes of Health (NIH) to continue its mission of accelerating research discoveries across Indiana and beyond.

The Indiana Clinical and Translational Sciences Institute is a partnership among Indiana University, Purdue University and Notre Dame to facilitate the translation of scientific discoveries in the lab into new patent treatments.

The Clinical and Translational Sciences Award from the NIH’s National Center for Advancing Translational Sciences renews the grant that established the Indiana CTSI five years ago, guaranteeing the institution will advance innovative health care programs and biomedical research into at least 2018.

The IU School of Medicine received the first $25 million NIH award to establish the Indiana CTSI in 2008, plus about $25 million in matching grants from IU and Purdue, the state of Indiana and public-private partners such as Eli Lilly and Co. Additional support arrived a year later when Notre Dame joined the partnership.

“The University of Notre Dame is pleased to be part of the Indiana Clinical and Translational Sciences Institute,” Robert Bernhard, Notre Dame’s vice president for research, said. “Our faculty and students benefit from having access to the infrastructure created by this grant to give us a bridge for our science and engineering discoveries to find their way to patients in need.”

Originally published by William G. Gilroy at news.nd.edu on October 28, 2013.